Objective: There are some studies on the prevalence of ectopic pregnancy (EP) in a different population of Iranian women. This study aimed to estimate the ectopic pregnancy prevalence in obstetrical clients and infertile patients treated by assisted reproductive technologies in Iran.
INTRODUCTION
About 303 000 maternal deaths occurred worldwide in 2015. 1 EP is one of the most significant causes of direct maternal death in early pregnancy. 2 EP is defined as implanting a fertilized egg outside the endometrium. Despite recent advances in EP diagnosis and treatment, EP has remained as the main cause of women's mortality and morbidity especially in low-income women 3 and in developing countries. 4 While in developed countries, EP case fatality rates are declining, in some developing countries, it has been reported to be around 1% to 3%, 10 times more than developed countries. 5 The prevalence of EP have been studied in different populations such as women aged 15 to 44 years receiving care in health services, 6 infertile patients treated with assisted reproductive technology (ART), 7, 8 and recorded deliveries in a hospital. 9 (2015) indicated that it is 17.12 per 1000 patients in the National ART Surveillance System 11 and Hoover et al (2010) showed that it is 6.4 per 1000 commercially insured girls and women aged 15 to 44 years. 12 However, in similar populations, the EP prevalence is more comparable. 3, 12 So, it seems that it is difficult to provide an exact and comparable prevalence of this type of pregnancy.
There are several studies on the prevalence of EP in a different population of Iranian women; some of them are based on files of obstetrical patients data in the records department of hospitals 13, 14 and some are based on infertile patients treated with ART data. 15, 16 These studies have indicated different results. Access to the best available data on the population disease rates is one of the first steps of maternal health planning and policy making, but the true prevalence of EP in Iran is not clear, yet. However, another systematic review has been published on the prevalence of EP in Iran recently, but total studies published in this area are not included in it. 17 So, this study was done to estimate the overall prevalence of EP among Iranian obstetrical clients and ART patients.
MATERIALS AND METHODS

Review registration
Protocol of the study has been registered in the international Prospective Register OF Systematic Reviews (PROSPERO) as number 2016: CRD42016032864, available online at http://www.crd.york.ac.uk/ PROSPERO_REBRANDING/display_record.asp?ID = CRD420160328 64. This study was a systematic review of published studies, so the ethics approval and informed consent did not need.
Definitions of ectopic pregnancy
The implantation of the fertilized egg in a location other than the uterus cavity, usually in the fallopian tubes, is defined as ectopic pregnancy. Its diagnosis is proven usually by human chorionic gonadotropin or hCG tests and pelvic ultrasound.
Systematic search
International databases were searched using the terms of "Prevalence," "Ectopic Pregnancies," "Pregnancies, Ectopic," "Pregnancy, Extrauterine," "Extrauterine Pregnancies," "Extrauterine Pregnancy," "Pregnancies, Extrauterine," "Ectopic Pregnancy," and "Iran." In addition, national databases were searched using the wide Persian term 
Study selection
All studies were included with the information available on the prevalence of EP in Iran regardless of publication date, language, and source of the study population. Iranian women who had any type of pregnancy were considered as the study population and the prevalence of EP in Iran was considered as the primary outcome of the study.
Data extraction
The title and abstract of the retrieved studies were screened by two authors (EA and PM), independently. The names of the journals and studies' authors were not blinded. Disagreements between the authors were resolved by negotiation and judgment with a third author (RKh). The two authors' percent agreement was 97.6% and the coefficient showed significant reliability among them ( = 77.3%, P < 0.001).
Variables including first author, year, province, design, the source of the study population, age, total number of participants, number of EP cases, and number of tubal and other pregnancy site cases were extracted into a data sheet. According to the Iranian Ministry of Interior's Management Development and Human Resources suggestions, five regions were defined based on the provinces of the studies. 18 
Risk of bias across studies
Statistical heterogeneity was assessed by chi-square test, inconsistency through study results by I 2 statistic, and between-study variance by 2 statistic. 19 Moreover, Begg and Egger's statistical tests were used to assess publication bias. 20,21
Subgroup analysis
Meta-regression was used to examine the sources of heterogeneity, based on the author's prior information about effective factors on the EP prevalence with the significance level of 0.2.
Data synthesis
Stata 11.0 (Stata Corp, College Station, TX, USA) and Review Manager 5.2 22 were used to data analysis. Summary measures of EP prevalence in the Iranian women population was obtained through meta-analysis and the results were reported by a random-effects model with 95% confidence interval (CI), using inverse variance weight. 23 
Risk of bias in the included studies
Eight selected items from the STROBE checklist were used to assess the quality of the included studies 24 including present key elements of study design, date, setting, outcome, eligibility criteria, sample size, statistical methods, and sampling of the studies. If the studies fulfilled all criteria (16 scores) they were categorized as high quality, if they did not fulfill two criteria (14-15 scores) as intermediate quality, and if they did not fulfill more than two criteria (less than 14 scores) as low quality.
The sensitivity of each study on the pooled prevalence was assessed using sequential exclusion of each study. Full-text arƟcles assessed for eligibility (n = 47)
Full-text arƟcles excluded, with reasons (n = 39)
Studies included in qualitaƟve synthesis (n = 8)
Studies included in quanƟtaƟve synthesis
(meta-analysis) (n = 8)
The flow diagram of selecting study
RESULTS
Study selection
Totally, 839 studies were retrieved up to January 2016, including 340 studies through international databases, 497 studies through national databases, and two studies through reference lists. Of these studies, 93 studies were eliminated because of duplication, 699 ones did not relate to the objective of this review, 38 ones did not meet the eligibility criteria, and one reference was republicized. Searching conference databases and contacting to study authors didn't cause to find the new study ( Figure 1 ).
Study characteristics
Finally, just eight studies included in the study [13] [14] [15] [16] [25] [26] [27] [28] that involved 571 826 women of whom 1446 had EP. Two studies of them reported the prevalence of EP in ART patients that involved 933 women of whom 56 had ectopic pregnancy, 15, 16 and six studies reported the prevalence of EP in obstetrical units of hospitals that involved 570 893 women of whom 1390 had ectopic pregnancy 13, 14, [25] [26] [27] [28] (Table 1) .
Seven of the studies were retrospective and one study was a prospective cohort. Just three studies 14, 25, 27 reported the prevalence of tubal ectopic pregnancies that involved 1085 women with ectopic pregnancies of whom 1032 had tubal EP. One study reported the prevalence of heterotopic pregnancy (both ectopic and in uterus pregnancy) that involved 336 438 women of whom two of them had it (data have not been shown).
Estimated prevalence of ectopic pregnancy
The overall prevalence of EP among Iranian women was 0.003 (95% CI (Table 2) .
Moreover, the tubal EP rate percent among patients with EP was 0.95 (95% CI: 0.92, 0.98).
Risk of bias across studies
The result of the chi-square test for heterogeneity was significant (P < 0.001), so there was considerable heterogeneity among the included studies. Also, the I 2 statistic was 97%. small ( 2 < 0.001) (Figure 2 ). Subgroup analysis by region, year, and source of the study population didn't cause to increase the homogeneity and decrease the heterogeneity. The results of Begg and Egger tests
were not statistically significant that proved the absence of publication bias.
Risk of bias in the included studies
The studies were allocated into three quality groups based on the STROBE checklist as follows: six studies (75%) had high quality; one study (12.5%) had moderate quality, and one study (12.5%) had low quality ( Figure 2 ). The prevalence of EP in high-quality studies was 
DISCUSSION
There are few studies on the EP prevalence in Iran. The total prevalence of EP was 3.1 per 1000 Iranian women. Also, the prevalence of EP was 2.9 per 1000 clients in the obstetrical units of hospitals and At first searches, there were a large number of studies with titles of, the prevalence of EP, the incidence rate of EP, or the EP related factors. So, it appeared that we could find a lot of studies in this area.
But during text and data assessment, most of them were case series or case control, which didn't have data for computing incidence rate or prevalence. Ultimately, eight studies remained. Thus, more studies are needed in this area in Iran. Moreover, our researchers are required to be educated in choosing more appropriate titles for their researches.
Just before submission of this article another systematic review published on the prevalence of EP in Iran, but that couldn't find total studies published in this area. 17 It is difficult to determine the true prevalence of EP from available data (hospitalizations and insurance billing records) because, in many of the cases, the early embryo (fertilized ovum) outside the uterus is absorbed before detection of pregnancy with negligible signs such as pain or bleeding. Furthermore, inpatient hospital management of EP has decreased and outpatient management has increased, and EP cases which are treated during outpatient visits cannot be recognized reliably. 29 The total prevalence of EP was 3.1 per 1000 Iranian women. Also, the prevalence of EP was 2.9 per 1000 clients in the obstetrical units of hospitals. In similar populations in other countries, there are different reports in this area. For example, the prevalence of EP has been reported to be 27.5 in 1000 pregnancies in Canada, 30 5.8 in 1000 medical record files of patients from obstetrics and gynecology units in Saudi Arabia, 31 11.41 in 1000 births in India, 3 7 in 1000 delivery and gynecology registers in South Kerala, 32 and 10.1 in 1000 deliveries in Pakistan. 9 The prevalence of EP in Iran was much lower than these studies, which may be due to differences in diagnostic criteria, quality and time of studies. Also, in this study, the prevalence of EP was underestimated in low-and medium-quality studies. Furthermore, it could be related to differences in the prevalence of EP related factors in different countries. For example, there is a direct correlation between EP prevalence and Chlamydia and Gonorrhea infections, 33 which are less common in Iran. 34 EP prevalence in ART patients was 5%. It was higher than studies in pregnancies following ART in the United Kingdom (1.4%), 35 and in patients in the National ART surveillance system in the United States (1.7%). 11 It was similar to a study in in vitro fertilization (IVF) and intra cytoplasmic sperm injection (ICSI) cycles performed in Germany (5.6%). 36 The prevalence of EP in ART patients could be related to the techniques used for treatment, previous pelvic inflammatory disease, pelvic surgery, endometriosis, salpingitis, tubal infertility, or unknown causes. 8, 35, 36 The prevalence of EP decreased in the studies between 2000 and 2005 compared to before 2000 and increased in the studies after 2005, which is consistent with some studies. 37 Also, the prevalence of EP was not consistent in all regions in Iran and it was highest in Tehran.
Consistent with this study, Stulberg et al (2014) showed that the incidence of EP varied in different states of the United States. 38 The high prevalence of EP in Tehran could be related to more studies in ART patients, there.
Heterogeneity between the results of the included studies was very high. The large sample sizes (571 826 women) in the metaanalysis, which has high power for detecting a small measure of heterogeneity, 19 could explain part of it. Another reason may be due to significant differences among studies results. The 2 statistic was small as well, showing the low between-studies variance and the high within-studies variance. 39 The prevalence of EP was underestimated in low-and moderate-quality studies. Therefore, it seems difficult to provide an exact estimation of the prevalence of EP in Iran. Additional evidence-based data on national high-quality studies may offer a more precise estimation of the EP prevalence in the country.
Low-and moderate-quality studies underestimated the prevalence of EP in Iran. As another limitation, the probability of the information bias couldn't be excluded as well, because there were differences in the source of the study population.
In conclusion, the results of this systematic review and metaanalysis indicated that there is very few evidence about the prevalence of EP in Iran. Furthermore, as there was substantial heterogeneity among the studies' results, more evidence-based studies on national population are needed to estimate the exact prevalence of EP in Iran.
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